Not that I’m advocating for the 300$b, but I think it’s erroneous to view that number as static, & I don’t mean year on year growth. I mean the fact that we are an immediate adjunct to a generic, which allows for greater use of the generic and doesn’t change the rest of the market, not 100% true but just in the interests of simplicity.
ie. If we were approved tomorrow that 300 could immediately be 320 or 350, pick your number, with the additive to 300 being all 99.999% revenue to RAC.
RAC Price at posting:
$1.41 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)